APOC3 and Alzheimer disease: ApoC-III co-localize with ganglioside GM1 alongside an increased tumor necrosis factor-α (TNF-α) levels; therefore, it has been supposed a potential proinflammatory role of ApoC-III involved in the blood–brain barrier destruction and amyloid β deposition in AD patients [73].